Simplex Trading
SUPN icon

Simplex Trading’s Supernus Pharmaceuticals SUPN Stock Holding History

Simplex Trading’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.17K Buy
+100
New +$5.09K ﹤0.01% 7871
2025
Q4 		– Sell
-5,500
Closed -$262K – 10009
2025
Q3 		$262K Buy
5,500
+4,900
+817% +$197K ﹤0.01% 4630
2025
Q2 		$18K Buy
600
+500
+500% +$16K ﹤0.01% 6874
2025
Q1 		$3K Sell
100
-100
-50% -$3.54K ﹤0.01% 7885
2024
Q4 		$7K Sell
200
-1,900
-90% -$66.9K ﹤0.01% 7453
2024
Q3 		$65K Buy
2,100
+1,700
+425% +$53.1K ﹤0.01% 5651
2024
Q2 		$10K Sell
400
-17,200
-98% -$499K ﹤0.01% 7451
2024
Q1 		$600K Buy
17,600
+16,400
+1,367% +$488K ﹤0.01% 3663
2023
Q4 		$34K Buy
1,200
+1,100
+1,100% +$29.2K ﹤0.01% 6462
2023
Q3 		$2K Buy
+100
New +$3.04K ﹤0.01% 8164
2023
Q2 		– Sell
-1,000
Closed -$36K – 9911
2023
Q1 		$36K Sell
1,000
-1,700
-63% -$65.4K ﹤0.01% 6307
2022
Q4 		$96K Sell
2,700
-1,300
-33% -$45.2K ﹤0.01% 5135
2022
Q3 		$135K Sell
4,000
-200
-5% -$6.51K ﹤0.01% 5115
2022
Q2 		$121K Sell
4,200
-57,500
-93% -$1.65M ﹤0.01% 5300
2022
Q1 		$1.99M Buy
61,700
+56,700
+1,134% +$1.74M ﹤0.01% 2117
2021
Q4 		$145K Hold
5,000
– – ﹤0.01% 5653
2021
Q3 		$156K Hold
5,000
– – ﹤0.01% 5988
2021
Q2 		$153K Buy
+5,000
New +$153K ﹤0.01% 6102
2021
Q1 		– Sell
-165
Closed -$415K – 9982
2020
Q4 		$415K Buy
165
+118
+251% +$2.54K ﹤0.01% 3672
2020
Q3 		$97K Buy
47
+33
+236% +$749 ﹤0.01% 4940
2020
Q2 		$33K Sell
14
-114
-89% -$2.52K ﹤0.01% 5857
2020
Q1 		$230K Sell
128
-307
-71% -$6.45K ﹤0.01% 3445
2019
Q4 		$1.03M Buy
435
+264
+154% +$6.41K ﹤0.01% 2068
2019
Q3 		$469K Buy
171
+167
+4,175% +$4.95K ﹤0.01% 2685
2019
Q2 		$13K Sell
4
-148
-97% -$5.07K ﹤0.01% 5959
2019
Q1 		$532K Sell
152
-162
-52% -$6.03K ﹤0.01% 2603
2018
Q4 		$1.04M Sell
314
-2
-0.6% -$86 ﹤0.01% 1599
2018
Q3 		$1.59M Buy
316
+262
+485% +$12.9K 0.01% 1442
2018
Q2 		$323K Buy
54
+2
+4% +$104 ﹤0.01% 2928
2018
Q1 		$10K Hold
52
– – ﹤0.01% 4052
2017
Q4 		$9K Sell
52
-28
-35% -$1.11K ﹤0.01% 4009
2017
Q3 		$6K Buy
80
+66
+471% +$2.86K ﹤0.01% 4270
2017
Q2 		$2K Sell
14
-80
-85% -$2.85K ﹤0.01% 5343
2017
Q1 		$50K Sell
94
-71
-43% -$1.9K ﹤0.01% 2370
2016
Q4 		$98K Sell
165
-222
-57% -$4.96K 0.01% 1550
2016
Q3 		$129K Buy
387
+333
+617% +$7.54K 0.01% 1353
2016
Q2 		$21K Sell
54
-80
-60% -$1.42K ﹤0.01% 2856
2016
Q1 		$27K Buy
134
+53
+65% +$692 ﹤0.01% 2519
2015
Q4 		$63K Sell
81
-1
-1% -$15 ﹤0.01% 1740
2015
Q3 		$70K Buy
82
+3
+4% +$56 0.01% 1727
2015
Q2 		$89K Buy
79
+34
+76% +$484 0.01% 1283
2015
Q1 		$22K Sell
45
-115
-72% -$1.09K ﹤0.01% 2265
2014
Q4 		$21K Buy
+160
New +$1.34K ﹤0.01% 2020

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's SUPN Position: Q1 2026 in Review

Simplex Trading opened a new position in Supernus Pharmaceuticals (SUPN) in Q1 2026: 2,850 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4651 among its holdings. This is a return to the name: Simplex Trading previously reported a position in SUPN as recently as Q3 2025.

Simplex Trading first reported a position in SUPN in Q2 2016 and has held it in 25 quarters since. The position peaked at $941K in Q4 2019. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Simplex Trading held 2,850 shares of Supernus Pharmaceuticals worth $147K as of Q1 2026.
  • Supernus Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4651 holding.
  • Simplex Trading first reported a position in Supernus Pharmaceuticals in Q2 2016 and has held it in 25 quarters since.
  • Simplex Trading's Supernus Pharmaceuticals position peaked at $941K in Q4 2019.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.